ICO
Closing Date:

Novel Therapeutic Approaches Targeting Microglia Biology for Neuroinflammatory Disorders

Novel Therapeutic Approaches Targeting Microglia Biology for Neuroinflammatory Disorders

Astellas Pharma Inc. are an international pharmaceutical company seeking novel research programs targeting microglia biology for neuroinflammatory and/or neuroimmunological disorders. Astellas are interested in microglia biology with a focus on disease/pathophysiology-specific microglia. This could include aspects of the following, as well as other microglia‑specific disease traits:

  • Lysosomal function
  • Pyroptosis
  • Autoimmune/inflammatory diseases

Target Diseases

Diseases of particular interest are neuroinflammatory disorders which have a strong/clear relevance...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology
  • Research Project
  • Spinout Company
  • Academic Researcher
  • Centre of Excellence

Essential Information

Submission Form

Share this call with professional partners.